Awards Categories

Companies investing their own capital in R&D to discover and develop new therapeutics to improve patient outcomes

Criteria:

• Novelty of mechanism, product or indication
• Investment raised and impact on development
• R&D deals signed – collaborations with companies or academia
• Company growth
• Patient engagement
• Effective ESG (environment, social, governance) strategy

Companies developing novel platform technologies to enable new therapeutics R&D

Criteria:

• Level of innovation
• Grant funding secured
• Investment and or collaborative R&D projects
• Company growth
• Talent and company culture development
• Effective ESG (environment, social, governance) strategy

Technology transfer offices, accelerators/incubators, start-up funders and advisers creating and supporting new ventures.

Criteria:

• New company creation activity
• Internal investment provided
• External investment secured into portfolio
• Business support provided
• Support of founder diversity
• Promotion of entrepreneurship in Life Sciences

Those organisations operating on a fee-for-service basis to provide one or more of research, development, manufacturing or clinical research services to other life science companies.

Criteria:

• Business performance
• Customer service performance
• Adoption of innovation into the services provided
• Flexibility of service provision
• Collaboration with Academia to enable translational research
• Effective ESG (environment, social, governance) strategy

Any business or individual whose core output is provision of advisory services or expertise to others on a fee-for-service basis

Criteria:

• Growth during the year in areas such as %revenue, physical expansion or client base
• Customer service performance
• Support of entrepreneurship
• Flexibility of engagement to support technology transfer offices, start-ups and early-stage companies
• Provision of educational sessions to academic and or industry groups
• Effective ESG (environment, social, governance) strategy

Those innovatively providing high quality, sustainable, flexible space solutions to support life science companies whether new build or retrofitting.

Criteria:

• Innovative design to enable modern life science R&D
• Excellence in environmental re-design of an existing space or minimising the environmental impact of a new build
• Creation of an innovation supporting environment
• Leasing terms flexibility to accommodate occupiers’ needs when plans change
• Engagement with the surrounding community to position life sciences as a positive contributor to society
• Support of entrepreneurship in life sciences

Those institutions, funded by one or more of government funding, donations, industry collaborations, grants or other that undertake directly or fund via grants laboratory research in biomedicine towards new therapies

Criteria:

• Significant scientific breakthrough/s and impact
• High impact publications from supported research
• Promotion of entrepreneurship and industrial collaboration among scientific researchers
• Patient engagement
• Promotion of careers in science to attract and develop future talent
• Addressing ED&I (equality, diversity and inclusion) in scientific research

Those individuals or organisations that have demonstrated creativity in dealmaking to attract and deploy capital to life science companies to fund R&D

Criteria:

• Investments made in companies with highly disruptive technologies, alternative business models or innovative commercialisation strategies
• Investments made in first-time founders
• Key opinion leadership in life science investment strategy
• Creativity in the deal structures
• Promotion of ESG (environment, social, governance) within investee companies
• Diversity of founders funded